BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26849435)

  • 21. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
    Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
    Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus.
    Yano S; Zhang Y; Miwa S; Kishimoto H; Urata Y; Bouvet M; Kagawa S; Fujiwara T; Hoffman RM
    BMJ Open Respir Res; 2015; 2(1):e000096. PubMed ID: 26380093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proof of concept of improved fluorescence-guided surgery of colon cancer liver metastasis using color-coded imaging of a tumor-labeling fluorescent antibody and indocyanine green restricted to the adjacent liver segment.
    Nishino H; Turner MA; Amirfakhri S; Hollandsworth HM; Lwin TM; Hosseini M; Framery B; Cailler F; Pèlegrin A; Hoffman RM; Bouvet M
    Surgery; 2022 Oct; 172(4):1156-1163. PubMed ID: 35927078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
    Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
    Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence-guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti-CEA DyLight 650 for tumor illumination.
    Miwa S; De Magalhães N; Toneri M; Zhang Y; Cao W; Bouvet M; Tsuchiya H; Hoffman RM
    J Orthop Res; 2016 Apr; 34(4):559-65. PubMed ID: 26135883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.
    Kikuchi S; Kishimoto H; Tazawa H; Hashimoto Y; Kuroda S; Nishizaki M; Nagasaka T; Shirakawa Y; Kagawa S; Urata Y; Hoffman RM; Fujiwara T
    Mol Ther; 2015 Mar; 23(3):501-9. PubMed ID: 25523761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
    Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic potential and limitation of imaging cancer cells in cytological samples using telomerase-specific replicative adenovirus.
    Maida Y; Kyo S; Sakaguchi J; Mizumoto Y; Hashimoto M; Mori N; Ikoma T; Nakamura M; Takakura M; Urata Y; Fujiwara T; Inoue M
    Int J Oncol; 2009 Jun; 34(6):1549-56. PubMed ID: 19424572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model.
    Miwa S; Hiroshima Y; Yano S; Zhang Y; Matsumoto Y; Uehara F; Yamamoto M; Kimura H; Hayashi K; Bouvet M; Tsuchiya H; Hoffman RM
    J Orthop Res; 2014 Dec; 32(12):1596-601. PubMed ID: 25138581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A GFP-labeled human colon cancer metastasis model featuring surgical orthotopic implantation.
    Chen HJ; Yang BL; Chen YG; Lin Q; Zhang SP; Gu YF
    Asian Pac J Cancer Prev; 2012; 13(9):4263-6. PubMed ID: 23167325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
    Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
    Yoon SN; Park JH; Lwin TM; Miyake K; Singh SR; Hoffman RM; Bouvet M
    Anticancer Res; 2019 Aug; 39(8):4065-4071. PubMed ID: 31366489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
    Uotani K; Tazawa H; Hasei J; Fujiwara T; Yoshida A; Yamakawa Y; Omori T; Sugiu K; Komatsubara T; Kondo H; Morita T; Kiyono M; Yokoo S; Hata T; Kunisada T; Takeda K; Urata Y; Fujiwara T; Ozaki T
    PLoS One; 2024; 19(2):e0298292. PubMed ID: 38377118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus.
    Kishimoto H; Kojima T; Watanabe Y; Kagawa S; Fujiwara T; Uno F; Teraishi F; Kyo S; Mizuguchi H; Hashimoto Y; Urata Y; Tanaka N; Fujiwara T
    Nat Med; 2006 Oct; 12(10):1213-9. PubMed ID: 17013385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
    Hoffman RM; Bouvet M
    Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.